My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Abbott Laboratories (NY:ABT)

125.92 -0.26 (-0.21%)

Official Closing Price Updated: 7:00 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

51 52 Next >

CBOE Volatility Index Drops To Lowest Level Since November 2021; S&P 500 Ends Almost Flat ↗

April 20, 2023

The S&P 500 closed almost flat on Wednesday following the release of corporate earnings.

Via Benzinga

Tesla, Rivian, IBM, Zions, Lam Research: Why These Five Stocks Are Drawing Investors' Attention Today ↗

April 19, 2023

Via Benzinga

Why Medtronic Stock Soared More Than 4% Higher Today ↗

April 19, 2023

The veteran device maker did well on a very good day for stocks in its industry.

Via The Motley Fool

Nasdaq Edges Higher; Abbott Laboratories Reports Upbeat Results ↗

April 19, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Wednesday. The Dow traded down 0.23% to 33,899.20 while the NASDAQ rose 0.16% to 12,172.92. The S&P 500,...

Via Benzinga

Abbott's Q1 Earnings Beat Estimates, Margins Down ↗

April 19, 2023

Abbott Laboratories reported first-quarter 2023 adjusted earnings of $1.03 per share.

Via Talk Markets

Check Out What Whales Are Doing With ABT ↗

April 19, 2023

Via Benzinga

Abbott Laboratories (NYSE: ABT) is a Leading Gainer in Wednesday Morning Trading

April 19, 2023

Via Investor Brand Network

Why Abbott Laboratories Shares Are Trading Higher Today? ↗

April 19, 2023

Via Benzinga

Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 19, 2023

Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.

Via Benzinga

Diversified Abbott Laboratories Could Reverse And Move Higher

April 19, 2023

Abbott Laboratories reported a solid quarter driven by gains in the core business that are accelerating as COVID sales decline.

Via MarketBeat

Abbott Labs Shakes Off Covid Test Decline To Top First-Quarter Estimates ↗

April 19, 2023

Covid tests are still expected to bring in $1.5 billion in sales this year.

Via Investor's Business Daily

New York Rep. Daniel Goldman Sold Over $50K Worth of Abbott Laboratories Stock: Here's What You Should Know ↗

April 18, 2023

Via Benzinga

A Preview Of Abbott Laboratories's Earnings ↗

April 18, 2023

Via Benzinga

Meta Prepares For Further Job Cuts, Google To Allow Developers To Use Alternative Payment Options, Intel Ditches Production Of Bitcoin Mining Chip: Today's Top Stories ↗

April 19, 2023

Bloomberg

Via Benzinga

2 Stocks That Could Help Make You a Millionaire by Retirement ↗

April 19, 2023

These companies are accustomed to delivering excellent returns.

Via The Motley Fool

Nasdaq, S&P Futures Falter As Mixed Earnings Weigh Down On Sentiment ↗

April 19, 2023

Earnings continue to be front and center in the market, with futures trading signaling a negative start on Wednesday. More bellwether names are due to turn in their quarterly scorecard, potentially...

Via Benzinga

10 Analysts Have This to Say About Abbott Laboratories ↗

April 05, 2023

Via Benzinga

Morgan Stanley, Tesla And 3 Stocks To Watch Heading Into Wednesday ↗

April 19, 2023

With US futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Investor Optimism Declines Following Earnings Reports ↗

April 19, 2023

The CNN Money Fear and Greed index showed some decline in overall sentiment among U.S. investors on Tuesday. U.S stocks closed mostly flat on Tuesday as investors digested the recent batch of earnings...

Via Benzinga

Major Earnings Misses And Beats: Your Guide To This Week's Big Earnings In Play ↗

April 18, 2023

We saw other large financial companies report their earnings along with stocks across other sectors miss or exceed expectations though the broader market was completely unchanged by the close.

Via Talk Markets

Abbott Laboratories, National Retail Properties, UnitedHealth Group And A Big Bank Reporting Upbeat Earnings: CNBC's 'Final Trades' ↗

April 18, 2023

On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors named Abbott Laboratories (NYSE: ABT)

Via Benzinga

Profit from the Artificial Intelligence Boom with These 7 AI ETFs ↗

April 17, 2023

The artificial intelligence revolution is already here, creating a massive $1.81 trillion opportunity for AI ETFs.

Via InvestorPlace

What's In Store For Abbott Laboratories In Q1 Earnings? ↗

April 15, 2023

Abbott Laboratories is slated to report first-quarter 2023 results on Apr. 19 before the market opens.

Via Talk Markets

3 No-Brainer Medical Device Stocks to Buy Right Now ↗

April 06, 2023

These companies have consistently delivered revenue and EPS gains.

Via The Motley Fool

3 Discounted Dividend Stocks With Combined 150+ Years Of Dividend Growth ↗

April 06, 2023

All three of these dividend stocks have paid a growing dividend for more than 25 years each

Via The Motley Fool

Better Dividend Stock: AbbVie vs. Johnson & Johnson ↗

April 05, 2023

Both companies have a lot to offer income-seekers.

Via The Motley Fool

3 Dividend-Growth Stocks to Buy in April That Can Crush Inflation ↗

April 02, 2023

No need to worry about keeping up with inflation with these rapidly growing payouts.

Via The Motley Fool

3 Healthcare Stocks to Watch As the Industry Evolves ↗

March 31, 2023

Healthcare stocks are often considered a safe investment due to the consistent demand for medical products and services.

Via InvestorPlace

2 Dividend Stocks Down 11% to 22% to Buy and Hold Forever ↗

March 28, 2023

Investors should buy the dips on these healthcare giants.

Via The Motley Fool

Can Healthcare Stocks Survive Macro Headwinds? ↗

March 27, 2023

Healthcare stocks are supposed to be defensive plays in a choppy market. However, over the past 18 months, the XLV is flat and down 6% over one year.

Via Talk Markets

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

51 52 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.